Evidence map›Paper›PMID 32803515›Full record

ArticleJournal of computer-aided molecular design2021

ReSCoSS: a flexible quantum chemistry workflow identifying relevant solution conformers of drug-like molecules.

Anikó Udvarhelyi, Stephane Rodde, Rainer Wilcken

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anikó UdvarhelyiTechnical Research and Development, Novartis Pharma AG, 4002, Basel, Switzerland. aniko.udvarhelyi@novartis.com.ORCID 0000-0002-6962-4722
Stephane RoddeGlobal Discovery Chemistry, Novartis Institutes for BioMedical Research, 4002, Basel, Switzerland.ORCID 0000-0001-6559-2420
Rainer WilckenGlobal Discovery Chemistry, Novartis Institutes for BioMedical Research, 4002, Basel, Switzerland. rainer.wilcken@novartis.com.ORCID 0000-0002-6159-1460

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conformational equilibria are at the heart of drug design, yet their energetic description is often hampered by the insufficient accuracy of low-cost methods. Here we present a flexible and semi-automatic workflow based on quantum chemistry, ReSCoSS, designed to identify relevant conformers and predict their equilibria across different solvent environments in the Conductor-like Screening Model for Real Solvents (COSMO-RS) framework. We demonstrate the utility and accuracy of the workflow through conformational case studies on several drug-like molecules from literature where relevant conformations are known. We further show that including ReSCoSS conformers significantly improves COSMO-RS based predictions of physicochemical properties over single-conformation approaches. ReSCoSS has found broad adoption in the in-house drug discovery and development work streams and has contributed to establishing quantum-chemistry methods as a strategic pillar in ligand discovery.

Indexed as

Drug DiscoveryQuantum TheoryModels, ChemicalModels, MolecularMolecular ConformationPharmaceutical PreparationsSmall Molecule LibrariesSolubilitySolventsThermodynamicsWorkflowPharmaceutical PreparationsSmall Molecule LibrariesSolventsConformationsCOSMO-RSGFN-xTBlogPQuantum chemistryReSCoSS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.